Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts [Yahoo! Finance]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Yahoo! Finance
The consensus estimated revenue numbers rose, with their view now clearly much more bullish on the company's business prospects. PTC Therapeutics has also found favour with investors, with the stock up a worthy 13% to US$28.57 over the past week. We'll be curious to see if these new estimates convince the market to lift the stock price higher still. Following the upgrade, the consensus from 13 analysts covering PTC Therapeutics is for revenues of US$672m in 2024, implying a sizeable 28% decline in sales compared to the last 12 months. Losses are predicted to fall substantially, shrinking 24% to US$5.76 per share. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$605m and losses of US$6.15 per share in 2024. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven. View our late
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts [Seeking Alpha]Seeking Alpha
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™PR Newswire
- PTC Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $30.00 price target on the stock, up previously from $28.00.MarketBeat
PTCT
Earnings
- 4/25/24 - Beat
PTCT
Sec Filings
- 5/10/24 - Form 4
- 5/8/24 - Form 4
- 5/7/24 - Form 144
- PTCT's page on the SEC website